Advancing capsid engineering: improving tropism and delivery efficiency of AAV

Abi Pinchbeck, Commissioning Editor, Cell & Gene Therapy Insights, speaks to Li Ou, Vice President of Research, Avirmax, Inc., exploring innovative approaches in next-­generation AAV capsid engineering. Addressing critical challenges, they discuss hurdles posed by the limited delivery efficiency of AAV capsids in addition to the ongoing battle of addressing lingering vector immunogenicity issues.

Please enter your email to access content Read now